Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users

Journal of Psychopharmacology

Volumn 20, Issue 3, 2006, Pages 389-399

  Reneman, Liesbeth ^a   Schilt, T ^a   De Win, Maartje M ^a   Booij, Jan ^a   Schmand, Ben ^a   Van Den Brink, Wim ^b   Bakker, Onno ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

Author keywords

5 HT neurotoxicity; 5 HTTLPR; Cognition; Long term effects; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DNA; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; ATTENTION; BLOOD CELL; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG ABUSE; DRUG WITHDRAWAL; FEMALE; GENDER; GENOTYPE; HUMAN; HUMAN CELL; MALE; MEMORY; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REACTION TIME; TASK PERFORMANCE;

ADULT; AMPHETAMINE-RELATED DISORDERS; ATTENTION; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOTYPE; HUMANS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REACTION TIME; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33645736683     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106063266     Document Type: Article

References (17)

1. Alpherts W, Aldenkamp A (1995) FEPSY The Iron Psychy 5.0A. Instituut voor Epilepsiebestrijding, Heemstede, The Netherlands
2. Altman H J, Normile H J (1988) What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia. Neurobiol Aging 9: 627-638
3. Benton A L, Hamsher K (1989) Multilingual Aphasia Examination. AJA Associates, Iowa City, IA
4. Bhattachary S, Powell J H (2001) Recreational use of 3,4- methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment. Psychol Med 31: 647-658
5. Bolla K I, McCann U D, Ricaurte G A (1998) Memory impairment in abstinent MDMA ('Ecstasy') users. Neurology 51: 1532-1537
6. Boot B P, McGregor I S, Hall W (2000) MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks. Lancet 355: 1818-1821
7. Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M (2004) A voxel-based PET investigation of the long-term effects of 'Ecstasy' consumption on brain serotonin transporters. Am J Psychiatry 161: 1181-1189
8. Buhot M C (1997) Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7: 243-254
9. Collier D A, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz M J, Murray R M, Vallada H P, Bengel D, Muller C R, Roberts G W, Smeraldi E, Kirov G, Sham P, Lesch K P (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1: 453-460
10. Commins D L, Vosmer G, Virus R M, Woolverton W L, Schuster C R, Seiden, L S (1987) Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241: 338-345
11. Croft R J, Mackay A J, Mills A T, Gruzelier J G (2001) The relative contributions of ecstacy and cannabis to cognitive impairment. Psychopharmacology 153: 373-379
12. Dafters R I, Hoshi R, Talbot A C (2004) Contribution of cannabis and MDMA ('ecstasy') to cognitive changes in long-term polydrug users. Psychopharmacology 173: 405-410
13. Daumann J Jr, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E (2004) Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biol Psychiatry 56: 349-355
14. Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E (2004) Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation. Psychopharmacology 173: 398-404
15. Du L, Faludi G, Palkovits M, Demeter E, Bakish D, Lapierre Y D, Sotonyi P, Hrdina P D (1999) Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry 46: 196-201
16. von Geusau NA, Stalenhoef P, Huizinga M, Snel J, Ridderinkhof K R (2004) Impaired executive function in male MDMA ('ecstasy') users. Psychopharmacology 175: 331-341.
17. Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J (2003) Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog Neuropsychopharmacol Biol Psychiatry 27: 819-827